Skip to Main content Skip to Navigation
Journal articles

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).

Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-00415127
Contributor : François-Xavier Maquart <>
Submitted on : Thursday, September 10, 2009 - 11:45:39 AM
Last modification on : Monday, August 31, 2020 - 9:52:05 AM

Identifiers

  • HAL Id : hal-00415127, version 1

Collections

Citation

M. Ychou, Raoul Jl, Douillard Jy, S. Gourgou-Bourgade, R. Bugat, et al.. A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).. Annals of Oncology, Elsevier, 2009, 20 (4), pp.674-680. ⟨hal-00415127⟩

Share

Metrics

Record views

107